Previous Close | 20.60 |
Open | N/A |
Bid | 34.50 |
Ask | 38.20 |
Strike | 240.00 |
Expire Date | 2024-11-15 |
Day's Range | 20.60 - 20.60 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
On June 13, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.